Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Acute Coronary Syndrome Market Insight, Epidemiology, and Market Forecast - 2036 — Reveals Why 2.2 Million Annual Cases Still Rely on Repurposed Antithrombotics, Not Disease-Modifying Therapy

globenewswire.com
IDXX NVO VTRS

New Copenhagen facility to strengthen Europe's quantum manufacturing capabilities

globenewswire.com
NVO

Global Anti-Obesity Drugs Market Report 2026: Set to Reach $106.5 Billion by 2035 as GLP-1 Therapies Transform Obesity Care

globenewswire.com
OPK NVO LLY TEVA

ElevateBio Appoints Steven Falcone as Chief Operating Officer

globenewswire.com
TMO AMGN NVO SNY

Wegovy Market Size Heads Toward USD 29.41 Billion by 2035 as GLP-1 Adoption Scales Worldwide – SNS Insider

globenewswire.com
NVO

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women

prnewswire.com
AMGN ARGX NVO

Innovation Through Collaboration Puts Precision BioLogic on the Map in Hemostasis Diagnostics and Research

prnewswire.com
NVO

Global Heart Failure Drugs Market to Reach $12.31 Billion by 2035 as Advanced Therapies Reshape Treatment - Industry Analysis and Sales Forecast (2026-2035)

globenewswire.com
AZN BMY LLY NVO

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent

globenewswire.com
NVO